Brawn Biotech reports standalone net loss of Rs 0.61 crore in the December 2023 quarter

Sales decline 54.99% to Rs 2.84 crore

Net Loss of Brawn Biotech reported to Rs 0.61 crore in the quarter ended December 2023 as against net loss of Rs 0.04 crore during the previous quarter ended December 2022. Sales declined 54.99% to Rs 2.84 crore in the quarter ended December 2023 as against Rs 6.31 crore during the previous quarter ended December 2022.

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	2.84	6.31	-55
OPM %	-20.42	-0.16	-
PBDT	-0.58	-0.01	-5700
PBT	-0.61	-0.04	-1425
NP	-0.61	-0.04	-1425

Powered by Capital Market - Live News